Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controll...
Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
About this item
Full title
Author / Creator
Mego, Michal , Chovanec, Jozef , Vochyanova-Andrezalova, Iveta , Konkolovsky, Peter , Mikulova, Milada , Reckova, Maria , Miskovska, Vera , Bystricky, Branislav , Beniak, Juraj , Medvecova, Lenka , Lagin, Adela , Svetlovska, Daniela , Spanik, Stanislav , Zajac, Vladimir , Mardiak, Jozef and Drgona, Lubos
Publisher
Scotland: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Scotland: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • Probiotics reduced grade 3–4 diarrhea after irinotecan based chemotherapy. • Probiotics reduced all grades of diarrhea and enterocolitis compared to placebo. • Patients on probiotics used less antidiarrheal drugs compared to placebo. • Probiotics could reduce gastrointestinal toxicity of irinotecan based therapy.
Alternative Titles
Full title
Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1746884764
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1746884764
Other Identifiers
ISSN
0965-2299
E-ISSN
1873-6963
DOI
10.1016/j.ctim.2015.03.008
